Ask the Expert: Alternative Therapies for Glaucoma
The only proven therapy for glaucoma is lowering interocular pressure. However, there’s a lot of interest from patients in knowing, “What else can I do?”
Menu
Menu
This is the place for the latest information about our work here at Glaucoma Research Foundation and for current events in the world of eye health. All breakthroughs and insights are made possible through the dedication of researchers, and through the continued financial support and active involvement of the community.
This is the place for the latest information about our work here at Glaucoma Research Foundation and for current events in the world of eye health. All breakthroughs and insights are made possible through the dedication of researchers, and through the continued financial support and active involvement of the community.
The only proven therapy for glaucoma is lowering interocular pressure. However, there’s a lot of interest from patients in knowing, “What else can I do?”
“I would say that the main takeaway point is to be an advocate for your care. From a patient view, you have to advocate for yourself.”
Dr. Ou summarizes recent advances in glaucoma research and highlights some of the most innovative and promising approaches to diagnosing glaucoma, curing glaucoma, and restoring vision.
David Epstein was diagnosed with glaucoma in his mid-twenties. “Glaucoma is a day-to-day tough battle,” he says.
Experts say guarding your eyes — as well as your hands and mouth — can slow the spread of coronavirus.
With 33 companies presenting innovations and 380 attendees, New Horizons Forum provided a boost of energy and commitment to the future of glaucoma diagnosis and treatment.
Following the latest guidelines for preventing disease transmission through safe hygiene and social distancing is expected to slow and ultimately end the spread of COVID-19.
There has been a remarkable expansion in understanding of the genetic underpinnings of the major forms of glaucoma. As research progresses, we hope to learn much more.
Glaucoma Research Foundation announced a total of $1.2 million in annual research grants to support 12 investigators at prestigious colleges and universities across the United States.
Allergan has announced the approval of DURYSTA™ (bimatoprost implant), the first biodegradable sustained-release implant for the treatment of open-angle glaucoma
For her research project “Eliminate to Protect,” Dr. Dorota Skowronska-Krawczyk from the University of California, San Diego was awarded the 2020 Shaffer Prize for Innovative Glaucoma Research.
Dr. Pickering delivered the Weston Glaucoma Research Lecture, “A New Era for Glaucoma,” in Palo Alto, California on October 22, 2019.
The Gleams Newsletter includes interviews, personal stories, and current information about glaucoma, new treatments, updates on research findings, and more. You can subscribe to the printed version of Gleams or the electronic version — both are free.
The Gleams Newsletter includes interviews, personal stories, and current information about glaucoma, new treatments, updates on research findings, and more. You can subscribe to the printed version of Gleams or the electronic version — both are free.
FOR EYECARE PROFESSIONALS
FOR EYECARE PROFESSIONALS
Glaucoma Research Foundation • 251 Post Street, Suite 600 • San Francisco, CA 94108 • 415-986-3162
Send us an email
We are a 501c3 tax-exempt national nonprofit. Our tax ID number is 94-2495035. Our EIN number is 94-2495035.
Copyright 2022 all rights reserved.
Print Subscription
(The printed edition of the Gleams newsletter is only available if you live in the United States or Canada)
You can unsubscribe at any time. GRF will not share your personal information with any other organizations. Please see our Privacy Policy for further information.
E-mail Subscription
You can unsubscribe at any time. GRF will not share your personal information with any other organizations. Please see our Privacy Policy for further information.